Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Flurazepam
Drug ID BADD_D00939
Description A benzodiazepine derivative used mainly as a hypnotic.
Indications and Usage For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Marketing Status Prescription; Discontinued
ATC Code N05CD01
DrugBank ID DB00690
KEGG ID D00329
MeSH ID D005479
PubChem ID 3393
TTD Drug ID D08XFV
NDC Product Code Not Available
Synonyms Flurazepam | Dalmane | Dalmadorm | Dormodor | Flurazepam Hydrochloride | Hydrochloride, Flurazepam | Flurazepam Dihydrochloride | Dihydrochloride, Flurazepam | Flurazepam Monohydrochloride | Monohydrochloride, Flurazepam | Staurodorm | Apo-Flurazepam | Apo Flurazepam | Flurazepam Mono-Perchlorate | Flurazepam Mono Perchlorate | Mono-Perchlorate, Flurazepam
Chemical Information
Molecular Formula C21H23ClFN3O
CAS Registry Number 17617-23-1
SMILES CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkinesia17.01.02.008--Not Available
Hypotension24.06.03.002--
Irritability19.04.02.013; 08.01.03.011--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukopenia01.02.02.001--Not Available
Logorrhoea17.02.08.006; 19.19.02.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Mental disability26.01.01.001--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Palpitations02.01.02.003--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Salivary hypersecretion07.06.01.009--Not Available
Shock24.06.02.002--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tension19.06.02.005--Not Available
Thinking abnormal17.02.05.023; 19.10.03.001--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Withdrawal syndrome19.07.02.005; 08.06.02.012--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Decreased appetite14.03.01.005; 08.01.09.028--
Drug intolerance08.06.01.013--Not Available
The 2th Page    First    Pre   2    Total 2 Pages